CO HB1214

Extends the Colorado Licensing of Controlled Substances Act from its September 1, 2026 repeal date to September 1, 2041, continuing the Behavioral Health Administration's record-keeping, licensing, and central registry functions for substance use disorder treatment programs.

Modernizes the definition of "substance use disorder" to a "chronic relapsing brain disease" diagnosed by licensed practitioners qualified to diagnose such conditions, replacing the previous definition requiring physician observation and tests.

Consolidates three separate treatment categories—"detoxification treatment," "maintenance treatment," and "withdrawal treatment"—into a single unified term "withdrawal management" that covers the full spectrum of treatment from short-term intoxication management to long-term medication management.

Narrows identity verification requirements for withdrawal management to apply specifically to "opioid treatment programs" treating persons with "opioid use disorder," rather than all substance use disorder treatment programs.

Removes obsolete defined terms no longer referenced in the act, including definitions for marijuana, marijuana concentrate, tetrahydrocannabinols, and production, redirecting statutory references to existing definitions in section 18-18-102.